Amgen Inc: (NASD: AMGN)

$104.53

0.29 (0.28%)

Volume 3,526,999

May 22 04:00 PM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Cash flow Statements

Get Cash flow Statements for:

Annual Cash Flow Statement

Fiscal Year End for AMGEN INC falls in the month of December.

All data in Millions except Per Share data.

Cash Flow From Operations, Investments & Financial Activities

12/31/12 12/31/11 12/31/10 12/31/09 12/31/08
Cash Flow From Operations, Investments & Financial
Activities
         
Net Income (Loss) 4,345.00 3,683.00 4,627.00 4,605.00 4,196.00
Depreciation/Amortization & Depletion 1,088.00 1,060.00 1,017.00 1,049.00 1,073.00
Net Change from Assets/Liabilities -45.00 365.00 -301.00 109.00 427.00
Net Cash from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Other Operating Activities 494.00 11.00 444.00 573.00 292.00
Net Cash From Operating Activities 5,882.00 5,119.00 5,787.00 6,336.00 5,988.00
Property & Equipment -689.00 -567.00 -580.00 -530.00 -672.00
Acquisition/ Disposition of Subsidiaries -2,390.00 -701.00 0.00 0.00 -56.00
Investments -6,875.00 437.00 -3,475.00 -2,723.00 -2,565.00
Other Investing Activities -36.00 45.00 -97.00 51.00 128.00
Net Cash from Investing Activities -9,990.00 -786.00 -4,152.00 -3,202.00 -3,165.00

Uses of Funds

12/31/12 12/31/11 12/31/10 12/31/09 12/31/08
Cash Flow From Operations, Investments & Financial
Activities
         
Net Income (Loss) 4,345.00 3,683.00 4,627.00 4,605.00 4,196.00
Depreciation/Amortization & Depletion 1,088.00 1,060.00 1,017.00 1,049.00 1,073.00
Net Change from Assets/Liabilities -45.00 365.00 -301.00 109.00 427.00
Net Cash from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Other Operating Activities 494.00 11.00 444.00 573.00 292.00
Net Cash From Operating Activities 5,882.00 5,119.00 5,787.00 6,336.00 5,988.00
Property & Equipment -689.00 -567.00 -580.00 -530.00 -672.00
Acquisition/ Disposition of Subsidiaries -2,390.00 -701.00 0.00 0.00 -56.00
Investments -6,875.00 437.00 -3,475.00 -2,723.00 -2,565.00
Other Investing Activities -36.00 45.00 -97.00 51.00 128.00
Net Cash from Investing Activities -9,990.00 -786.00 -4,152.00 -3,202.00 -3,165.00
Issuance (Repurchase) of Capital Stock -3,319.00 -7,553.00 -3,706.00 -3,037.00 -2,113.00
Issuance (Repayment) of Debt 4,810.00 7,887.00 2,471.00 980.00 -1,009.00
Increase (Decrease) Short-Term Debt 0.00 -762.00 0.00 0.00 0.00
Payment of Dividends & Other Distributions -1,118.00 -500.00 0.00 0.00 0.00
Other Financing Activities 46.00 254.00 3.00 33.00 49.00
Net Cash from Financing Activities 419.00 -674.00 -1,232.00 -2,024.00 -3,073.00
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00 0.00
Net Change In Cash & Equivalents -3,689.00 3,659.00 403.00 1,110.00 -250.00
Cash at Beginning of Period 6,946.00 3,287.00 2,884.00 1,774.00 2,024.00
Cash at End of Period 3,257.00 6,946.00 3,287.00 2,884.00 1,774.00
Diluted Net EPS 5.52 4.04 4.79 4.51 3.90

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.